| RS1440842317 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS144084678 |
SERPINC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS144084915 |
TSHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypothyroidism due to TSH receptor mutations, Familial hyperthyroidism due to mutations in TSH receptor |
| RS144085622 |
MECOM
|
Health Risk |
Conflicting classifications of pathogenicity |
MECOM-related disorder, Inborn genetic diseases |
| RS144085805 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS144085962 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hajdu-Cheney syndrome, Alagille syndrome due to a NOTCH2 point mutation |
| RS144085995 |
IL17RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 51, Immunodeficiency 51 |
| RS144086049 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
POLE-related disorder, Hereditary cancer-predisposing syndrome |
| RS1440862488 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS144086377 |
LEMD3
|
Health Risk |
Conflicting classifications of pathogenicity |
LEMD3-related disorder, LEMD3-related disorder |
| RS144086611 |
CNTRL
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS144087221 |
IFT57
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS144087359 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS144087445 |
PC
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS144087607 |
NDUFV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Mitochondrial complex I deficiency |
| RS144087649 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, SETBP1-related disorder |
| RS144088322 |
MAP1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hearing loss |
| RS1440884580 |
LAMB2
|
Health Risk |
Likely pathogenic |
LAMB2-related infantile-onset nephrotic syndrome, Pierson syndrome |
| RS1440888766 |
CD3G
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to CD3gamma deficiency, Combined immunodeficiency due to CD3gamma deficiency |
| RS1440888810 |
BCL11B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1440890027 |
LDHA
|
Health Risk |
Pathogenic |
Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency, Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency |
| RS1440898011 |
ABCD4
|
Health Risk |
Pathogenic |
Methylmalonic acidemia with homocystinuria, type cblJ |
| RS144090917 |
GLDC
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycine encephalopathy, Cervical cancer |
| RS144091165 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS1440911824 |
TG
|
Health Risk |
Pathogenic |
— |
| RS1440913446 |
P3H2
|
Health Risk |
Pathogenic/Likely pathogenic |
P3H2-related disorder, P3H2-related disorder |
| RS144091742 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
PKD1-related disorder, Inborn genetic diseases |
| RS1440918649 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1440920591 |
SLC5A5
|
Health Risk |
Likely pathogenic |
— |
| RS144092577 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS144092780 |
QARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome, QARS1-related disorder |
| RS144093133 |
INS
|
Health Risk |
Conflicting classifications of pathogenicity |
INS-related disorder, INS-related disorder |
| RS144093705 |
HADHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial trifunctional protein deficiency, Mitochondrial trifunctional protein deficiency |
| RS1440946792 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1440947266 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1440948694 |
ABCA1
|
Health Risk |
Likely pathogenic |
Hypoalphalipoproteinemia, primary |
| RS144095207 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS144095826 |
SLC2A10
|
Health Risk |
Conflicting classifications of pathogenicity |
Arterial tortuosity syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1440975003 |
NPHS1
|
Health Risk |
Pathogenic |
— |
| RS144098289 |
MMP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Metaphyseal anadysplasia 2, Gastric cancer |
| RS144098531 |
LCA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS144098854 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS144099208 |
HDAC4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS144099251 |
IVD
|
Health Risk |
Likely pathogenic |
Isovaleryl-CoA dehydrogenase deficiency, Isovaleryl-CoA dehydrogenase deficiency |
| RS144099376 |
MAT1A
|
Health Risk |
Pathogenic |
Hepatic methionine adenosyltransferase deficiency, Hepatic methionine adenosyltransferase deficiency |
| RS144099488 |
CNGA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia 2, Inborn genetic diseases |
| RS144099489 |
ENPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatemic rickets, autosomal recessive |
| RS144099522 |
HPS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome, Hermansky-Pudlak syndrome 3 |
| RS144099604 |
POLR3F
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS144100380 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS144100614 |
NLRP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 2, Inborn genetic diseases |
| RS1441014377 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS144101806 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, myofibrillar |
| RS1441030187 |
GAMT
|
Health Risk |
Pathogenic |
Cerebral creatine deficiency syndrome, Deficiency of guanidinoacetate methyltransferase |
| RS144103035 |
HOGA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary hyperoxaluria type 3, Inborn genetic diseases |
| RS1441030917 |
COL12A1
|
Health Risk |
Likely pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS144103124 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Dystrophin deficiency |
| RS144103228 |
PIGO
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS144104172 |
GPR179
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1E, GPR179-related disorder |
| RS144104577 |
PGM3
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency 23, Severe combined immunodeficiency disease |
| RS144104914 |
PKD1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS144105769 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS144106169 |
ATP1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemiplegic migraine, Inborn genetic diseases |
| RS144106341 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, PKHD1-related disorder |
| RS144106775 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular cardiomyopathy, Arrhythmogenic right ventricular dysplasia 8 |
| RS1441084539 |
FDXR
|
Health Risk |
Likely pathogenic |
Auditory neuropathy-optic atrophy syndrome, Auditory neuropathy-optic atrophy syndrome |
| RS144109267 |
CYP4V2
|
Health Risk |
Pathogenic |
— |
| RS144109380 |
TSFM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3, Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 |
| RS1441100300 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group G |
| RS144110783 |
FOCAD
|
Health Risk |
Conflicting classifications of pathogenicity |
FOCAD-related disorder, Inborn genetic diseases |
| RS144111552 |
MMADHC
|
Health Risk |
Conflicting classifications of pathogenicity |
Disorders of Intracellular Cobalamin Metabolism, Methylmalonic aciduria and homocystinuria type cblD |
| RS144111588 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1441120961 |
ZEB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mowat-Wilson syndrome, Inborn genetic diseases |
| RS144112103 |
BBS9
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, BBS9-related disorder |
| RS1441136255 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS144115061 |
SMCHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS1441151762 |
EYA4
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1J, Dilated cardiomyopathy 1J |
| RS1441152520 |
SPTAN1
|
Health Risk |
Pathogenic |
Self-limited epilepsy with centrotemporal spikes, Self-limited epilepsy with centrotemporal spikes |
| RS144115463 |
COG1
|
Health Risk |
Conflicting classifications of pathogenicity |
COG1 congenital disorder of glycosylation, COG1 congenital disorder of glycosylation |
| RS1441154788 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS144115730 |
SLC26A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS144116037 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS144116311 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Werner syndrome |
| RS144116735 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1441174171 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1441183063 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS144118442 |
MPI
|
Health Risk |
Conflicting classifications of pathogenicity |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS144118534 |
LAMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMC3-related disorder, Inborn genetic diseases |
| RS144118716 |
NPHS1
|
Health Risk |
Likely pathogenic |
— |
| RS144118960 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS1441197277 |
SLC37A4
|
Health Risk |
Pathogenic |
Glucose-6-phosphate transport defect, Glucose-6-phosphate transport defect |
| RS1441200320 |
TRIOBP
|
Health Risk |
Pathogenic |
— |
| RS144120746 |
KCND3
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 19/22, Cardiovascular phenotype |
| RS144120866 |
WDR62
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 2, primary |
| RS144120903 |
VIPAS39
|
Health Risk |
Conflicting classifications of pathogenicity |
Arthrogryposis, renal dysfunction |
| RS144121978 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS144122107 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1441228030 |
SLC12A3
|
Health Risk |
Likely pathogenic |
— |
| RS144122901 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, Inborn genetic diseases |
| RS1441230589 |
LZTR1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |